Targeted surgical parathyroidectomy in end‐stage renal disease patients and long‐term metabolic control: A single‐center experience in the current era
Tibor Fülöp(Medical University of South Carolina), Mehul Dixit(Jackson Memorial Hospital), Abdeen R. Farah Musa(University of Mississippi Medical Center), Karen T. Pitman(University of Mississippi Medical Center), Mehrdad Hamrahian(Thomas Jefferson University), Kamel A. Gharaibeh(University of Maryland, Baltimore), Christopher M. Clark(Institute on Aging), Christian A. Koch, Zsolt Lengvársky(Louisiana State University in Shreveport)
Cited by 13
Related Papers
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
|The Lancet Neurology|2012|846
Consortium to Establish a Registry for Alzheimer's Disease (CERAD): The first twenty years
|Alzheimer s & Dementia|2008|491
Florbetapir (F18‐AV‐45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
|Alzheimer s & Dementia|2013|265
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline
|Neurology|2012|228